HealthCare Global Enterprises P / E
Was ist das P / E von HealthCare Global Enterprises?
P / E von HealthCare Global Enterprises Limited ist N/A
Was ist die Definition von P / E?
Das Terminkurs-Gewinn-Verhältnis ist das Verhältnis des Aktienkurses eines Unternehmens zum geschätzten Gewinn des Unternehmens je Aktie für die nächsten zwölf Monate.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P / E von Unternehmen in Health Care Sektor auf NSE im Vergleich zu HealthCare Global Enterprises
Was macht HealthCare Global Enterprises?
HealthCare Global Enterprises Limited, together with its subsidiaries, provides healthcare services focusing on cancer and fertility. The company offers cancer diagnosis and treatment services through radiation therapy, medical oncology, and surgery; and fertility treatment services, as well as reproductive medicine services, including assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates four multi-specialty hospitals, including three under the HCG brand in Ahmedabad, Bhavnagar, and Rajkot in the state of Gujarat, as well as one under operations and management contract in Hubli in the state of Karnataka that primarily provide cardiology, neurology, orthopedics, gastroenterology, urology, internal medicine, and pulmonary and critical care. In addition, the company offers medical diagnostic services, including scientific testing and consultancy services in the pharmaceutical and medical sector. As of March 31, 2022, the company operated 22 comprehensive cancer centers, including 1 center in Africa. The company was founded in 1989 and is based in Bengaluru, India.
Unternehmen mit p / e ähnlich HealthCare Global Enterprises
- Jiangsu Jingyuan Environmental Protection Co hat P / E von N/A
- Wuxi Shangji Automation Co hat P / E von N/A
- Hotel Rugby hat P / E von N/A
- Basilea Pharmaceutica AG hat P / E von N/A
- Heritage Foods hat P / E von N/A
- Eurazeo SA hat P / E von N/A
- HealthCare Global Enterprises hat P / E von N/A
- Affluent Partners hat P / E von N/A
- Galileo Mining Ltd hat P / E von N/A
- Cardero Resource hat P / E von N/A
- Monumental Gold hat P / E von N/A
- Monumental Gold Corp hat P / E von N/A
- SML Isuzu hat P / E von N/A